关注
Robert Haddad, M.D.
Robert Haddad, M.D.
Professor, Dana Farber Cancer Institute, Harvard Medical School, McGraw Chair Head and Neck Oncology
在 dfci.harvard.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Nivolumab for recurrent squamous-cell carcinoma of the head and neck
RL Ferris, G Blumenschein Jr, J Fayette, J Guigay, AD Colevas, L Licitra, ...
New England Journal of Medicine 375 (19), 1856-1867, 2016
46442016
Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer
MR Posner, DM Hershock, CR Blajman, E Mickiewicz, E Winquist, ...
New England Journal of Medicine 357 (17), 1705-1715, 2007
20702007
Recent advances in head and neck cancer
RI Haddad, DM Shin
New England Journal of Medicine 359 (11), 1143-1154, 2008
11372008
Antitumor activity of pembrolizumab in biomarker-unselected patients with recurrent and/or metastatic head and neck squamous cell carcinoma: results from the phase Ib KEYNOTE …
LQM Chow, R Haddad, S Gupta, A Mahipal, R Mehra, M Tahara, R Berger, ...
Journal of Clinical Oncology 34 (32), 3838, 2016
8602016
Head and neck cancers, version 2.2020, NCCN clinical practice guidelines in oncology
DG Pfister, S Spencer, D Adelstein, D Adkins, Y Anzai, DM Brizel, ...
Journal of the National Comprehensive Cancer Network 18 (7), 873-898, 2020
8252020
Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck …
R Haddad, A O'Neill, G Rabinowits, R Tishler, F Khuri, D Adkins, J Clark, ...
The Lancet Oncology 14 (3), 257-264, 2013
7672013
Nivolumab vs investigator’s choice in recurrent or metastatic squamous cell carcinoma of the head and neck: 2-year long-term survival update of CheckMate 141 with analyses by …
RL Ferris, G Blumenschein Jr, J Fayette, J Guigay, AD Colevas, L Licitra, ...
Oral oncology 81, 45-51, 2018
7492018
Head and neck cancers, version 2.2014
DG Pfister, S Spencer, DM Brizel, B Burtness, PM Busse, JJ Caudell, ...
Journal of the National Comprehensive Cancer Network 12 (10), 1454-1487, 2014
7292014
Pembrolizumab for platinum-and cetuximab-refractory head and neck cancer: results from a single-arm, phase II study
J Bauml, TY Seiwert, DG Pfister, F Worden, SV Liu, J Gilbert, NF Saba, ...
Journal of Clinical Oncology 35 (14), 1542, 2017
6592017
NCCN guidelines insights: head and neck cancers, version 1.2018
AD Colevas, SS Yom, DG Pfister, S Spencer, D Adelstein, D Adkins, ...
Journal of the National Comprehensive Cancer Network 16 (5), 479-490, 2018
5642018
Survival and human papillomavirus in oropharynx cancer in TAX 324: a subset analysis from an international phase III trial
MR Posner, JH Lorch, O Goloubeva, M Tan, LM Schumaker, NJ Sarlis, ...
Annals of oncology 22 (5), 1071-1077, 2011
5442011
Induction chemotherapy with cisplatin and fluorouracil alone or in combination with docetaxel in locally advanced squamous-cell cancer of the head and neck: long-term results …
JH Lorch, O Goloubeva, RI Haddad, K Cullen, N Sarlis, R Tishler, M Tan, ...
The lancet oncology 12 (2), 153-159, 2011
5032011
Genomic correlates of response to immune checkpoint blockade in microsatellite-stable solid tumors
D Miao, CA Margolis, NI Vokes, D Liu, A Taylor-Weiner, SM Wankowicz, ...
Nature genetics 50 (9), 1271-1281, 2018
5022018
Afatinib versus methotrexate as second-line treatment in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck progressing on or after platinum …
JPH Machiels, RI Haddad, J Fayette, LF Licitra, M Tahara, JB Vermorken, ...
The Lancet Oncology 16 (5), 583-594, 2015
462*2015
Characterization of HPV and host genome interactions in primary head and neck cancers
M Parfenov, CS Pedamallu, N Gehlenborg, SS Freeman, L Danilova, ...
Proceedings of the National Academy of Sciences 111 (43), 15544-15549, 2014
4222014
Head and neck cancer
MD Mody, JW Rocco, SS Yom, RI Haddad, NF Saba
The Lancet 398 (10318), 2289-2299, 2021
4162021
Efficacy and safety of pembrolizumab in recurrent/metastatic head and neck squamous cell carcinoma: pooled analyses after long-term follow-up in KEYNOTE-012
R Mehra, TY Seiwert, S Gupta, J Weiss, I Gluck, JP Eder, B Burtness, ...
British journal of cancer 119 (2), 153-159, 2018
4052018
Nivolumab versus standard, single-agent therapy of investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141): health-related …
KJ Harrington, RL Ferris, G Blumenschein, AD Colevas, J Fayette, ...
The Lancet Oncology 18 (8), 1104-1115, 2017
4042017
Avelumab plus standard-of-care chemoradiotherapy versus chemoradiotherapy alone in patients with locally advanced squamous cell carcinoma of the head and neck: a randomised …
NY Lee, RL Ferris, A Psyrri, RI Haddad, M Tahara, J Bourhis, K Harrington, ...
The Lancet Oncology 22 (4), 450-462, 2021
3722021
Response and acquired resistance to everolimus in anaplastic thyroid cancer
N Wagle, BC Grabiner, EM Van Allen, A Amin-Mansour, A Taylor-Weiner, ...
New England Journal of Medicine 371 (15), 1426-1433, 2014
3592014
系统目前无法执行此操作,请稍后再试。
文章 1–20